Skip to main content
. 2021 Oct 29;13(21):5456. doi: 10.3390/cancers13215456

Figure 1.

Figure 1

Therapeutic strategy for early-stage OPSCC. a some T1–T2, N1 OPSCC patients with a small unique ipsilateral metastatic lymph node can be classified in this category. b adverse pathological features include close/positive surgical margins, perineural or vascular invasion, metastatic lymph node(s), and extracapsular spread. The preferred therapeutic option, if any, is in bold and underlined.